Mary Broadfoot Walker (1888-1974): A historic discovery in myasthenia gravis

European Neurology

Volumn 53, Issue 1, 2005, Pages 51-53

  Pearce, J M S ^a,b  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

History; Myasthenia gravis; Physostigmine; Thymus

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ATROPINE; EPHEDRINE; NEOSTIGMINE; PHYSOSTIGMINE SALICYLATE; PILOCARPINE; STRYCHNINE;

CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; MYASTHENIA GRAVIS; PRIORITY JOURNAL; REVIEW; THYMECTOMY; THYMUS;

CHOLINESTERASE INHIBITORS; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MYASTHENIA GRAVIS; PHYSICIANS; PHYSOSTIGMINE;

EID: 17144421271     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084268     Document Type: Review

References (15)

1. Wilks S: On cerebritis, hysteria and bulbar paralysis, as illustrative of arrest of function of the cerebrospinal centres. Guys Hosp Rep 1877;22:7-55.
2. Willis T: De anima brutorum quae hominis vitalis ac sentitiva est: exercitationes duae. Davis, Oxon, 1672, pp 404-406.
3. Pearce JMS: Fragments of Neurological History. London, Imperial College Press, 2003, pp 459-462.
4. Jolly F: Über Myasthenia gravis pseudoparalytica. Berl Klin Wochenschr 1895;32:1-7.
5. Weigert C: Pathologisch-anatomischer Beitrag zur Erb'schen Krankheit [Myasthenia gravis]. Leipzig, Neurologisches Centralblatt, 1901, vol 20, pp 597-601.
6. Walker MB: Treatment of myasthenia gravis with physostigmine. Lancet 1934;i:1200-1201.
7. Walker MB: Some discoveries on myasthenia gravis: The background. Br Med J 1973;2:42-43.
8. Walker MB: Potassium chloride in myasthenia gravis. Lancet 1935;ii:47.
9. Aitken RS, Allot EN, Gastelden LIM, Walker MB: Observations on a case of familial periodic paralysis. Clin Sci 1937;3:47-57.
10. Mary Broadfoot Walker. Lancet 1974;ii:1401.
11. Keesey JC: Contemporary opinions about Mary Walker. A shy pioneer of therapeutic neurology. Neurology 1998;51:1433-1439.
12. Keeney AH, Keeney VT: Mary B. Walker, MB and the pioneering use of prostigmin to treat myasthenia gravis. Doc Ophthalmol 1997;93:125-134.
13. Buckley C, Douek D, Newsom-Davis J, et al: Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 2001;50:64-72.
14. Simpson JA: Myasthenia gravis: A new hypothesis. Scott Med J 1960;5:419-436.
15. Osserman KE, Genkins G: Studies in myasthenia gravis: Review of a twenty-year experience in over 1,200 patients. Mt Sinai J Med 1971;38:497-537.